Exact Mass: 715.372

Exact Mass Matches: 715.372

Found 75 metabolites which its exact mass value is equals to given mass value 715.372, within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error 0.01 dalton.

Saquinavir-NO

N-{4-[3-(tert-butyl-C-hydroxycarbonimidoyl)-decahydroisoquinolin-2-yl]-3-(nitrooxy)-1-phenylbutan-2-yl}-2-[(quinolin-2-yl)formamido]butanediimidate

C38H49N7O7 (715.3693)


   
   
   

Nummularine O

N-Desmethyljubanine B

C42H45N5O6 (715.337)


   

3-Acetyl-15-veratroylgermine

3-Acetyl-15-veratroylgermine

C38H53NO12 (715.3568)


   
   

9alpha,13alpha-diacetoxy-10beta-benzyloxy-5alpha-(3-dimethylamino-3-phenyl)-propionyloxy-11(15->1)abeotaxa-4(20),11-diene-15-ol

9alpha,13alpha-diacetoxy-10beta-benzyloxy-5alpha-(3-dimethylamino-3-phenyl)-propionyloxy-11(15->1)abeotaxa-4(20),11-diene-15-ol

C42H53NO9 (715.372)


   

Phe Gln Phe Phe Lys

Phe Gln Phe Phe Lys

C38H49N7O7 (715.3693)


   

Phenalinolactone A

Phenalinolactone A

C38H53NO12 (715.3568)


   

FQFFK

Phe Gln Phe Phe Lys

C38H49N7O7 (715.3693)


   

erbium tris(2,2,6,6-tetramethyl-3,5-heptanedionate)

erbium tris(2,2,6,6-tetramethyl-3,5-heptanedionate)

C33H57ErO6 (715.3458)


   

Boc-Gln-Arg-Arg-AMC

Boc-Gln-Arg-Arg-AMC

C32H49N11O8 (715.3765)


   

H-Gly-Arg-Gly-Asp-Ser-Pro-Lys-OH acetate salt

H-Gly-Arg-Gly-Asp-Ser-Pro-Lys-OH acetate salt

C28H49N11O11 (715.3613)


GRGDSPK (EMD 56574) is a peptide incluing Arg-Gly-Asp (RGD). GRGDSPK (EMD 56574) is an competitive and reversible inhibitory peptide for inhibiting integrin-fibronectin binding. GRGDSPK is used to study the role of integrins in bone formation and resorption[1][2].

   

2-O-[N-(3-(aminopropyl)2-aminoethyl]paromomycin

2-O-[N-(3-(aminopropyl)2-aminoethyl]paromomycin

C28H57N7O14 (715.3963)


   

N-{4-[3-(tert-butylcarbamoyl)-octahydro-1H-isoquinolin-2-yl]-3-(nitrooxy)-1-phenylbutan-2-yl}-2-(quinolin-2-ylformamido)succinamide

N-{4-[3-(tert-butylcarbamoyl)-octahydro-1H-isoquinolin-2-yl]-3-(nitrooxy)-1-phenylbutan-2-yl}-2-(quinolin-2-ylformamido)succinamide

C38H49N7O7 (715.3693)


   

Anthrose tetrasaccharide

Anthrose tetrasaccharide

C30H53NO18 (715.3262)


   

Human neocasomorphin(1-)

Human neocasomorphin(1-)

C35H51N6O10- (715.3666)


   
   
   

N-[(E)-1-[5-[3,4-dihydroxy-6-(hydroxymethyl)-5-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]oxy-3,4-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-3-hydroxydec-4-en-2-yl]acetamide

N-[(E)-1-[5-[3,4-dihydroxy-6-(hydroxymethyl)-5-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]oxy-3,4-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-3-hydroxydec-4-en-2-yl]acetamide

C30H53NO18 (715.3262)


   

(7Z,10Z,13Z)-N-[(E)-1-[3,4-dihydroxy-6-(hydroxymethyl)-5-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]oxy-3-hydroxyoct-4-en-2-yl]hexadeca-7,10,13-trienamide

(7Z,10Z,13Z)-N-[(E)-1-[3,4-dihydroxy-6-(hydroxymethyl)-5-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]oxy-3-hydroxyoct-4-en-2-yl]hexadeca-7,10,13-trienamide

C36H61NO13 (715.4143)


   

N-[(E)-1-[5-[3,4-dihydroxy-6-(hydroxymethyl)-5-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]oxy-3,4-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-3-hydroxynon-4-en-2-yl]propanamide

N-[(E)-1-[5-[3,4-dihydroxy-6-(hydroxymethyl)-5-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]oxy-3,4-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-3-hydroxynon-4-en-2-yl]propanamide

C30H53NO18 (715.3262)


   

(4Z,7Z,10Z,13Z)-N-[1-[3,4-dihydroxy-6-(hydroxymethyl)-5-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]oxy-3-hydroxyoctan-2-yl]hexadeca-4,7,10,13-tetraenamide

(4Z,7Z,10Z,13Z)-N-[1-[3,4-dihydroxy-6-(hydroxymethyl)-5-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]oxy-3-hydroxyoctan-2-yl]hexadeca-4,7,10,13-tetraenamide

C36H61NO13 (715.4143)


   

N-[(E)-1-[5-[3,4-dihydroxy-6-(hydroxymethyl)-5-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]oxy-3,4-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-3-hydroxyoct-4-en-2-yl]butanamide

N-[(E)-1-[5-[3,4-dihydroxy-6-(hydroxymethyl)-5-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]oxy-3,4-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-3-hydroxyoct-4-en-2-yl]butanamide

C30H53NO18 (715.3262)


   

(2S)-2-amino-3-[2,3-bis[[(5E,7E,9E,11E,13E)-hexadeca-5,7,9,11,13-pentaenoyl]oxy]propoxy-hydroxyphosphoryl]oxypropanoic acid

(2S)-2-amino-3-[2,3-bis[[(5E,7E,9E,11E,13E)-hexadeca-5,7,9,11,13-pentaenoyl]oxy]propoxy-hydroxyphosphoryl]oxypropanoic acid

C38H54NO10P (715.3485)


   

[2-[(5E,7E,9E,11E,13E)-hexadeca-5,7,9,11,13-pentaenoyl]oxy-3-[(7E,9E,11E,13E)-hexadeca-7,9,11,13-tetraenoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

[2-[(5E,7E,9E,11E,13E)-hexadeca-5,7,9,11,13-pentaenoyl]oxy-3-[(7E,9E,11E,13E)-hexadeca-7,9,11,13-tetraenoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C40H62NO8P (715.4213)


   

[3-[(5E,7E,9E,11E,13E)-hexadeca-5,7,9,11,13-pentaenoyl]oxy-2-[(7E,9E,11E,13E)-hexadeca-7,9,11,13-tetraenoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

[3-[(5E,7E,9E,11E,13E)-hexadeca-5,7,9,11,13-pentaenoyl]oxy-2-[(7E,9E,11E,13E)-hexadeca-7,9,11,13-tetraenoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C40H62NO8P (715.4213)


   

[3-[2-aminoethoxy(hydroxy)phosphoryl]oxy-2-[(7E,9E,11E,13E)-hexadeca-7,9,11,13-tetraenoyl]oxypropyl] (4E,7E,10E,13E,16E)-nonadeca-4,7,10,13,16-pentaenoate

[3-[2-aminoethoxy(hydroxy)phosphoryl]oxy-2-[(7E,9E,11E,13E)-hexadeca-7,9,11,13-tetraenoyl]oxypropyl] (4E,7E,10E,13E,16E)-nonadeca-4,7,10,13,16-pentaenoate

C40H62NO8P (715.4213)


   

[3-[2-aminoethoxy(hydroxy)phosphoryl]oxy-2-[(5E,7E,9E,11E,13E)-hexadeca-5,7,9,11,13-pentaenoyl]oxypropyl] (7E,10E,13E,16E)-nonadeca-7,10,13,16-tetraenoate

[3-[2-aminoethoxy(hydroxy)phosphoryl]oxy-2-[(5E,7E,9E,11E,13E)-hexadeca-5,7,9,11,13-pentaenoyl]oxypropyl] (7E,10E,13E,16E)-nonadeca-7,10,13,16-tetraenoate

C40H62NO8P (715.4213)


   

neocasomorphin(1-)

neocasomorphin(1-)

C35H51N6O10 (715.3666)


A peptide anion obtained from the deprotonation of the two carboxy groups, and protonation of the primary amino group of neocasomorphin. It is the major species at pH 7.3.

   

MePC(31:9)

MePC(20:5_11:4)

C40H62NO8P (715.4213)


Provides by LipidSearch Vendor. © Copyright 2006-2024 Thermo Fisher Scientific Inc. All rights reserved

   

PC(32:9)

PC(22:6_10:3)

C40H62NO8P (715.4213)


Provides by LipidSearch Vendor. © Copyright 2006-2024 Thermo Fisher Scientific Inc. All rights reserved

   
   
   
   
   

PE 20:2/11:3;O3

PE 20:2/11:3;O3

C36H62NO11P (715.406)


   
   
   
   
   

PS P-18:1/11:4;O3

PS P-18:1/11:4;O3

C35H58NO12P (715.3696)


   

PS P-18:1/12:3;O2

PS P-18:1/12:3;O2

C36H62NO11P (715.406)


   
   
   
   
   
   
   
   
   
   
   
   
   
   

ST 28:1;O8;HexNAc

ST 28:1;O8;HexNAc

C36H61NO13 (715.4143)


   

IZCZ-3

IZCZ-3

C46H49N7O (715.3998)


IZCZ-3 is a potent c-MYC transcription inhibitor with antitumor activity[1].

   

12,15-dibenzyl-14,17,20-trihydroxy-3,18-bis(2-methylpropyl)-4-oxa-1,10,13,16,19-pentaazatricyclo[19.3.0.0⁶,¹⁰]tetracosa-13,16,19-triene-2,5,11-trione

12,15-dibenzyl-14,17,20-trihydroxy-3,18-bis(2-methylpropyl)-4-oxa-1,10,13,16,19-pentaazatricyclo[19.3.0.0⁶,¹⁰]tetracosa-13,16,19-triene-2,5,11-trione

C40H53N5O7 (715.3945)


   

n-(1-{10-benzyl-8,11-dihydroxy-16-methoxy-2-oxa-6,9,12-triazatricyclo[13.3.1.0³,⁷]nonadeca-1(18),8,11,13,15(19),16-hexaen-6-yl}-1-oxo-3-phenylpropan-2-yl)-2-(methylamino)-3-phenylpropanimidic acid

n-(1-{10-benzyl-8,11-dihydroxy-16-methoxy-2-oxa-6,9,12-triazatricyclo[13.3.1.0³,⁷]nonadeca-1(18),8,11,13,15(19),16-hexaen-6-yl}-1-oxo-3-phenylpropan-2-yl)-2-(methylamino)-3-phenylpropanimidic acid

C42H45N5O6 (715.337)


   

(2r,3s)-n-[(3r)-1-hydroxy-2-oxoazepan-3-yl]-3-{[(2s)-2-({hydroxy[2-(2-hydroxyphenyl)-5-methyl-1,3-oxazol-4-yl]methylidene}amino)-6-(n-hydroxyacetamido)hexanoyl]oxy}-2-methyldecanimidic acid

(2r,3s)-n-[(3r)-1-hydroxy-2-oxoazepan-3-yl]-3-{[(2s)-2-({hydroxy[2-(2-hydroxyphenyl)-5-methyl-1,3-oxazol-4-yl]methylidene}amino)-6-(n-hydroxyacetamido)hexanoyl]oxy}-2-methyldecanimidic acid

C36H53N5O10 (715.3792)


   

n-(1-hydroxy-2-oxoazepan-3-yl)-3-{[2-({hydroxy[2-(2-hydroxyphenyl)-5-methyl-1,3-oxazol-4-yl]methylidene}amino)-6-(n-hydroxyacetamido)hexanoyl]oxy}-2-methyldecanimidic acid

n-(1-hydroxy-2-oxoazepan-3-yl)-3-{[2-({hydroxy[2-(2-hydroxyphenyl)-5-methyl-1,3-oxazol-4-yl]methylidene}amino)-6-(n-hydroxyacetamido)hexanoyl]oxy}-2-methyldecanimidic acid

C36H53N5O10 (715.3792)


   

2-[(2-{[(1-{2-[(2-amino-9-chlorononyl)amino]-3-methylbutanoyl}pyrrolidin-2-yl)(hydroxy)methylidene]amino}-1-hydroxy-3-(4-hydroxyphenyl)propylidene)amino]-3-(4-hydroxyphenyl)propanoic acid

2-[(2-{[(1-{2-[(2-amino-9-chlorononyl)amino]-3-methylbutanoyl}pyrrolidin-2-yl)(hydroxy)methylidene]amino}-1-hydroxy-3-(4-hydroxyphenyl)propylidene)amino]-3-(4-hydroxyphenyl)propanoic acid

C37H54ClN5O7 (715.3712)


   

(7e,9s,10s,11s,12e,14s,16e,20s,21s,22e,24z,26z)-4,10,14,20,28-pentahydroxy-31-methoxy-3,7,9,11,17,21,27-heptamethyl-29-azatricyclo[28.3.1.0⁵,³³]tetratriaconta-1(33),2,4,7,12,16,22,24,26,28,30-undecaene-6,18,32,34-tetrone

(7e,9s,10s,11s,12e,14s,16e,20s,21s,22e,24z,26z)-4,10,14,20,28-pentahydroxy-31-methoxy-3,7,9,11,17,21,27-heptamethyl-29-azatricyclo[28.3.1.0⁵,³³]tetratriaconta-1(33),2,4,7,12,16,22,24,26,28,30-undecaene-6,18,32,34-tetrone

C41H49NO10 (715.3356)


   

(2s,3as,4ar,6s,8ar,9r,10r)-2,9-bis(acetyloxy)-6-{[(3r)-3-(dimethylamino)-3-phenylpropanoyl]oxy}-3a-(2-hydroxypropan-2-yl)-1,8a-dimethyl-5-methylidene-2h,3h,4h,4ah,6h,7h,8h,9h,10h-cyclohexa[f]azulen-10-yl benzoate

(2s,3as,4ar,6s,8ar,9r,10r)-2,9-bis(acetyloxy)-6-{[(3r)-3-(dimethylamino)-3-phenylpropanoyl]oxy}-3a-(2-hydroxypropan-2-yl)-1,8a-dimethyl-5-methylidene-2h,3h,4h,4ah,6h,7h,8h,9h,10h-cyclohexa[f]azulen-10-yl benzoate

C42H53NO9 (715.372)


   

2,9-bis(acetyloxy)-6-{[3-(dimethylamino)-3-phenylpropanoyl]oxy}-3a-(2-hydroxypropan-2-yl)-1,8a-dimethyl-5-methylidene-2h,3h,4h,4ah,6h,7h,8h,9h,10h-cyclohexa[f]azulen-10-yl benzoate

2,9-bis(acetyloxy)-6-{[3-(dimethylamino)-3-phenylpropanoyl]oxy}-3a-(2-hydroxypropan-2-yl)-1,8a-dimethyl-5-methylidene-2h,3h,4h,4ah,6h,7h,8h,9h,10h-cyclohexa[f]azulen-10-yl benzoate

C42H53NO9 (715.372)


   

[2-(acetyloxy)-8-(2,4-dihydroxy-5-oxo-2h-furan-3-yl)-4-hydroxy-1-{[(5-methoxy-6-methyloxan-2-yl)oxy]methyl}-4a,7,8a-trimethyl-3,4,4b,5,8,9,10,10a-octahydro-2h-phenanthren-1-yl]methyl 5-methyl-1h-pyrrole-2-carboxylate

[2-(acetyloxy)-8-(2,4-dihydroxy-5-oxo-2h-furan-3-yl)-4-hydroxy-1-{[(5-methoxy-6-methyloxan-2-yl)oxy]methyl}-4a,7,8a-trimethyl-3,4,4b,5,8,9,10,10a-octahydro-2h-phenanthren-1-yl]methyl 5-methyl-1h-pyrrole-2-carboxylate

C38H53NO12 (715.3568)


   

16-(acetyloxy)-10,12,14,23-tetrahydroxy-6,10,19-trimethyl-13-[(2-methylbut-2-enoyl)oxy]-24-oxa-4-azaheptacyclo[12.12.0.0²,¹¹.0⁴,⁹.0¹⁵,²⁵.0¹⁸,²³.0¹⁹,²⁵]hexacosan-22-yl 2-methylbut-2-enoate

16-(acetyloxy)-10,12,14,23-tetrahydroxy-6,10,19-trimethyl-13-[(2-methylbut-2-enoyl)oxy]-24-oxa-4-azaheptacyclo[12.12.0.0²,¹¹.0⁴,⁹.0¹⁵,²⁵.0¹⁸,²³.0¹⁹,²⁵]hexacosan-22-yl 2-methylbut-2-enoate

C39H57NO11 (715.3931)


   

[(1r,2r,4s,4as,4br,8r,8ar)-2-(acetyloxy)-8-(2,4-dihydroxy-5-oxo-2h-furan-3-yl)-4-hydroxy-1-{[(5-methoxy-6-methyloxan-2-yl)oxy]methyl}-4a,7,8a-trimethyl-3,4,4b,5,8,9,10,10a-octahydro-2h-phenanthren-1-yl]methyl 5-methyl-1h-pyrrole-2-carboxylate

[(1r,2r,4s,4as,4br,8r,8ar)-2-(acetyloxy)-8-(2,4-dihydroxy-5-oxo-2h-furan-3-yl)-4-hydroxy-1-{[(5-methoxy-6-methyloxan-2-yl)oxy]methyl}-4a,7,8a-trimethyl-3,4,4b,5,8,9,10,10a-octahydro-2h-phenanthren-1-yl]methyl 5-methyl-1h-pyrrole-2-carboxylate

C38H53NO12 (715.3568)


   

(3s)-n-[(3s)-1-hydroxy-2-oxoazepan-3-yl]-3-{[(2r)-2-({hydroxy[2-(2-hydroxyphenyl)-5-methyl-1,3-oxazol-4-yl]methylidene}amino)-6-(n-hydroxyformamido)hexanoyl]oxy}-2,2-dimethyldecanimidic acid

(3s)-n-[(3s)-1-hydroxy-2-oxoazepan-3-yl]-3-{[(2r)-2-({hydroxy[2-(2-hydroxyphenyl)-5-methyl-1,3-oxazol-4-yl]methylidene}amino)-6-(n-hydroxyformamido)hexanoyl]oxy}-2,2-dimethyldecanimidic acid

C36H53N5O10 (715.3792)


   

[(2r,4s,4as,4br,8r,8ar,10as)-2-(acetyloxy)-8-(2,4-dihydroxy-5-oxo-2h-furan-3-yl)-4-hydroxy-1-({[(2r,5r,6s)-5-methoxy-6-methyloxan-2-yl]oxy}methyl)-4a,7,8a-trimethyl-3,4,4b,5,8,9,10,10a-octahydro-2h-phenanthren-1-yl]methyl 5-methyl-1h-pyrrole-2-carboxylate

[(2r,4s,4as,4br,8r,8ar,10as)-2-(acetyloxy)-8-(2,4-dihydroxy-5-oxo-2h-furan-3-yl)-4-hydroxy-1-({[(2r,5r,6s)-5-methoxy-6-methyloxan-2-yl]oxy}methyl)-4a,7,8a-trimethyl-3,4,4b,5,8,9,10,10a-octahydro-2h-phenanthren-1-yl]methyl 5-methyl-1h-pyrrole-2-carboxylate

C38H53NO12 (715.3568)


   

(1s,2s,6s,9s,10s,11r,12r,13s,14s,15s,16r,18s,19s,22s,23s,25r)-16-(acetyloxy)-10,12,14,23-tetrahydroxy-6,10,19-trimethyl-13-{[(2z)-2-methylbut-2-enoyl]oxy}-24-oxa-4-azaheptacyclo[12.12.0.0²,¹¹.0⁴,⁹.0¹⁵,²⁵.0¹⁸,²³.0¹⁹,²⁵]hexacosan-22-yl (2z)-2-methylbut-2-enoate

(1s,2s,6s,9s,10s,11r,12r,13s,14s,15s,16r,18s,19s,22s,23s,25r)-16-(acetyloxy)-10,12,14,23-tetrahydroxy-6,10,19-trimethyl-13-{[(2z)-2-methylbut-2-enoyl]oxy}-24-oxa-4-azaheptacyclo[12.12.0.0²,¹¹.0⁴,⁹.0¹⁵,²⁵.0¹⁸,²³.0¹⁹,²⁵]hexacosan-22-yl (2z)-2-methylbut-2-enoate

C39H57NO11 (715.3931)


   

(3r)-n-[(3s)-1-hydroxy-2-oxoazepan-3-yl]-3-{[(2r)-2-({hydroxy[2-(2-hydroxyphenyl)-5-methyl-1,3-oxazol-4-yl]methylidene}amino)-6-(n-hydroxyformamido)hexanoyl]oxy}-2,2-dimethyldecanimidic acid

(3r)-n-[(3s)-1-hydroxy-2-oxoazepan-3-yl]-3-{[(2r)-2-({hydroxy[2-(2-hydroxyphenyl)-5-methyl-1,3-oxazol-4-yl]methylidene}amino)-6-(n-hydroxyformamido)hexanoyl]oxy}-2,2-dimethyldecanimidic acid

C36H53N5O10 (715.3792)


   

(3s,6s,12s,15s,18s,21s)-12,15-dibenzyl-14,17,20-trihydroxy-3,18-bis(2-methylpropyl)-4-oxa-1,10,13,16,19-pentaazatricyclo[19.3.0.0⁶,¹⁰]tetracosa-13,16,19-triene-2,5,11-trione

(3s,6s,12s,15s,18s,21s)-12,15-dibenzyl-14,17,20-trihydroxy-3,18-bis(2-methylpropyl)-4-oxa-1,10,13,16,19-pentaazatricyclo[19.3.0.0⁶,¹⁰]tetracosa-13,16,19-triene-2,5,11-trione

C40H53N5O7 (715.3945)